PeerVoice Endocrinology & Metabolic Disorders Video
PeerVoice
72 episodes
2 days ago
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
All content for PeerVoice Endocrinology & Metabolic Disorders Video is the property of PeerVoice and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
David Jones, OBE, MD, PhD - New Options and Opportunities for Personalised Treatment of Primary Biliary Cholangitis: Have You Updated Your Approach?
PeerVoice Endocrinology & Metabolic Disorders Video
41 minutes 3 seconds
2 days ago
David Jones, OBE, MD, PhD - New Options and Opportunities for Personalised Treatment of Primary Biliary Cholangitis: Have You Updated Your Approach?
Visit https://www.peervoice.com/RNT860 to view the entire programme with slides. After completing “David Jones, OBE, MD, PhD - New Options and Opportunities for Personalised Treatment of Primary Biliary Cholangitis: Have You Updated Your Approach?”, participants will be able to: Describe the contemporary approach to pharmacologic treatment of primary biliary cholangitis (PBC); Identify individuals with PBC who may benefit from initiation of second-line treatment options or a transition in second-line treatment approach; and Apply available data to guide the personalisation of second-line treatment choice for individuals with PBC based on person- and disease-specific characteristics (eg, presence of moderate-to-severe pruritus or compensated cirrhosis, prior treatment with fibrates or obeticholic acid [OCA]).
PeerVoice Endocrinology & Metabolic Disorders Video
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
